Growth Metrics

Biolife Solutions (BLFS) Long-Term Debt Issuances (2016 - 2022)

Biolife Solutions (BLFS) has disclosed Long-Term Debt Issuances for 8 consecutive years, with $20.0 million as the latest value for Q3 2022.

  • On a quarterly basis, Long-Term Debt Issuances rose 1660.06% to $20.0 million in Q3 2022 year-over-year; TTM through Dec 2023 was $20.0 million, a 0.0% change, with the full-year FY2022 number at $20.0 million, up 1190.32% from a year prior.
  • Long-Term Debt Issuances was $20.0 million for Q3 2022 at Biolife Solutions, up from $1.5 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $20.0 million in Q3 2022 to a low of -$1.3 million in Q3 2021.